These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9585022)

  • 61. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.
    Chausserie S; Levillain R; Puvinel J; Ferrand O; Ruiz A; Raginel T; Lantieri O; Launoy G; Guittet L
    Int J Cancer; 2015 Apr; 136(8):1827-34. PubMed ID: 25195670
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood.
    Castiglione G; Grazzini G; Miccinesi G; Rubeca T; Sani C; Turco P; Zappa M
    J Med Screen; 2002; 9(3):99-103. PubMed ID: 12370319
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Should organised faecal occult blood test screening be established?
    Autier P
    Ann Oncol; 2002 Jan; 13(1):57-60. PubMed ID: 11863112
    [No Abstract]   [Full Text] [Related]  

  • 64. [Screening and prevention of colorectal cancer].
    Faivre J; Manfredi S
    Rev Prat; 2015 Jun; 65(6):774-8. PubMed ID: 26298898
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fecal occult blood screening for colorectal cancer.
    Van Dam J; Bond JH; Sivak MV
    Arch Intern Med; 1995 Dec 11-25; 155(22):2389-402. PubMed ID: 7503597
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Colorectal cancer screening.
    McLoughlin RM; O'Morain CA
    World J Gastroenterol; 2006 Nov; 12(42):6747-50. PubMed ID: 17106920
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Colorectal cancer: implications of mass screening for public health.
    Woodward A; Weller D
    Med J Aust; 1990 Jul; 153(2):81-2, 85-8. PubMed ID: 2288572
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Colorectal cancer screening: optimal compliance with postal faecal occult blood test.
    King J; Fairbrother G; Thompson C; Morris DL
    Aust N Z J Surg; 1992 Sep; 62(9):714-9. PubMed ID: 1520154
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparison of three stool tests for colorectal cancer screening.
    Greenwald B
    Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
    Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
    Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
    Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
    Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
    Malila N; Hakama M; Pukkala E
    Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study.
    Saito H; Soma Y; Koeda J; Wada T; Kawaguchi H; Sobue T; Aisawa T; Yoshida Y
    Int J Cancer; 1995 May; 61(4):465-9. PubMed ID: 7759151
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A new immunological test strip device for the rapid, qualitative detection of faecal occult blood.
    Trojan J; Povse N; Schröder O; Stein J
    Z Gastroenterol; 2002 Nov; 40(11):921-4. PubMed ID: 12436369
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Screening for colorectal tumors using fecal occult blood studies].
    Restellini A; Margalith D; Bauerfeind P; Guyot J; Ollyo JB; Gonvers JJ; Blum AL
    Ther Umsch; 1989 Jun; 46(6):389-97. PubMed ID: 2667190
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.